Full Text View
Tabular View
No Study Results Posted
Related Studies
Influence of the Proton Pump Inhibitor Omeprazole on the Anti-Platelet of P2Y12 Antagonists in Subjects With Coronary and Peripheral Artery Disease
This study is ongoing, but not recruiting participants.
Study NCT01018940   Information provided by University of Oklahoma

First Received on November 23, 2009.   Last Updated on February 6, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Coronary Artery Disease
Peripheral Artery Disease
Additional conditions recognized in this trial
Coronary Disease
Myocardial Ischemia
Peripheral Arterial Disease
More general conditions related to this trial
Arterial Occlusive Diseases
Arteriosclerosis
Atherosclerosis
Cardiovascular Diseases
Heart Diseases
Peripheral Vascular Diseases
Vascular Diseases
Additional drug interventions recognized in this trial
Omeprazole
Proton Pump Inhibitors
More general drug interventions related to this trial
Anti-Ulcer Agents
Enzyme Inhibitors
Gastrointestinal Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
University of Oklahoma


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services